Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study. (Q46038574)
Jump to navigation
Jump to search
scientific article published in May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study. |
scientific article published in May 2009 |
Statements
1 reference
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study. (English)
1 reference
1 reference
1 reference
Daniel Podzamczer
1 reference
Bonaventura Clotet
1 reference
Josep Mallolas
1 reference
Pere Domingo
1 reference
Esteve Ribera
1 reference
Félix Gutiérrez
1 reference
Hernando Knobel
1 reference
Jaime Cosin
1 reference
Elena Ferrer
1 reference
José Alberto Arranz
1 reference
Victor Roca
1 reference
Javier Murillas
1 reference
Judit Pich
1 reference
Enric Pedrol
1 reference
Josep M Llibre
1 reference
David Dalmau
1 reference
Isabel GarcÃa
1 reference
Miquel Aranda
1 reference
Ana Cruceta
1 reference
Esteban MartÃnez
1 reference
José L Blanco
1 reference
José M Gatell
1 reference
ATAZIP Study Group
1 reference
1 May 2009
1 reference
51
1 reference
29-36
1 reference
1
1 reference
Identifiers
1 reference
1 reference